Issued Patents All Time
Showing 1–25 of 27 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11957760 | Folate receptor targeted nanoparticle drug conjugates and uses thereof | Kai Ma, Aranapakam Mudumbai Venkatesan, Feng-Jing Chen, Fei Wu, Melik Z. Turker +3 more | 2024-04-16 |
| 11744897 | Folate receptor targeted nanoparticle drug conjugates and uses thereof | Kai Ma, Aranapakam Mudumbai Venkatesan, Feng-Jing Chen, Fei Wu, Melik Z. Turker +3 more | 2023-09-05 |
| 10112941 | Tricyclic compounds as anticancer agents | Derek J. Norris, George V. DeLucca, Ashvinikumar V. Gavai, John S. Tokarski | 2018-10-30 |
| 9751879 | Tricyclic compounds as anticancer agents | Derek J. Norris, George V. DeLucca, Ashvinikumar V. Gavai, Claude A. Quesnelle, Patrice Gill +12 more | 2017-09-05 |
| 9492469 | Combination therapy for the treatment of proliferative diseases | — | 2016-11-15 |
| 9458156 | Tricyclic compounds as anticancer agents | Derek J. Norris, George V. DeLucca, Ashvinikumar V. Gavai, John S. Tokarski | 2016-10-04 |
| 9273014 | Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof | Ashvinikumar V. Gavai, George V. DeLucca, Daniel O'Malley, Patrice Gill, Claude A. Quesnelle +2 more | 2016-03-01 |
| 8999918 | Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof | Ashvinikumar V. Gavai, George V. DeLucca, Daniel O'Malley, Patrice Gill, Claude A. Quesnelle +2 more | 2015-04-07 |
| 8673949 | Use of epothilone D in treating Tau-associated diseases including Alzheimer's disease | Charles F. Albright, Donna Marie Barten | 2014-03-18 |
| 8629136 | Bisfluoroalkyl-1,4-benzodiazepinone compounds | Ashvinikumar V. Gavai, Claude A. Quesnelle, Soong-Hoon Kim | 2014-01-14 |
| 8598215 | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases | — | 2013-12-03 |
| 8569347 | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases | — | 2013-10-29 |
| 8247419 | Methods of identifying and treating individuals exhibiting mutant kit protein | Michael Heinrich | 2012-08-21 |
| 8119129 | Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases | Maria Jure-Kunkel | 2012-02-21 |
| 7799788 | Method of treating chronic myelogenous leukemia cells | Kapil N. Bhalla | 2010-09-21 |
| RE41393 | Treatment of refractory tumors using epothilone derivatives | — | 2010-06-22 |
| 7622472 | Combination of Src kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases | — | 2009-11-24 |
| 7537891 | Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells | Fei Huang, Xia Han, Karen Reeves, Lukas C. Amler, Craig R. Fairchild +1 more | 2009-05-26 |
| 7504211 | Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells | Fei Huang, Xia Han, Karen Reeves, Lukas C. Amler, Craig R. Fairchild +1 more | 2009-03-17 |
| 7265260 | Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors | David Bol, Joan Carboni, Ronald Rowley, Tai W. Wong | 2007-09-04 |
| 7125875 | Cyclic protein tyrosine kinase inhibitors | Jagabandhu Das, Ramesh Padmanabha, Ping Chen, Derek J. Norris, Arthur M. P. Doweyko +3 more | 2006-10-24 |
| 7053069 | Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives | Thomas Arthur HABY, Vijay H. Naringrekar, Krishnaswamy Srinivas Raghavan, Miriam K. Franchini | 2006-05-30 |
| 6936628 | Oral administration of epothilones | — | 2005-08-30 |
| 6773702 | Use of combretastatin A4 and its prodrugs as an immune enhancing therapy | Ronald W. Pero, Klaus Edvardsen, Hans Olov Sjogren | 2004-08-10 |
| 6727276 | Epothilone derivatives for the treatment of refractory tumors | — | 2004-04-27 |